Rank | Gene Set | Z-score |
---|---|---|
1 | positive thymic T cell selection (GO:0045059) | 5.52393229 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.43196194 |
3 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.66061023 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.65674029 |
5 | positive T cell selection (GO:0043368) | 4.49477052 |
6 | negative thymic T cell selection (GO:0045060) | 4.40203947 |
7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.36245642 |
8 | cellular response to interleukin-15 (GO:0071350) | 4.26457057 |
9 | response to interleukin-15 (GO:0070672) | 4.18685323 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.17539773 |
11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.17539773 |
12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.11400315 |
13 | negative regulation of cell killing (GO:0031342) | 4.11400315 |
14 | thymic T cell selection (GO:0045061) | 4.06122404 |
15 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.99389501 |
16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.90712987 |
17 | immunoglobulin mediated immune response (GO:0016064) | 3.90015234 |
18 | positive regulation of B cell differentiation (GO:0045579) | 3.89214176 |
19 | neutrophil activation involved in immune response (GO:0002283) | 3.83962643 |
20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.77406344 |
21 | modulation by symbiont of host defense response (GO:0052031) | 3.77406344 |
22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.77406344 |
23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.77406344 |
24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.77406344 |
25 | modulation by symbiont of host immune response (GO:0052553) | 3.77406344 |
26 | mast cell activation (GO:0045576) | 3.77158853 |
27 | response to peptidoglycan (GO:0032494) | 3.75112153 |
28 | T cell selection (GO:0045058) | 3.67706615 |
29 | regulation of RIG-I signaling pathway (GO:0039535) | 3.66474947 |
30 | B cell receptor signaling pathway (GO:0050853) | 3.66099998 |
31 | regulation of B cell differentiation (GO:0045577) | 3.63660804 |
32 | ribosomal small subunit assembly (GO:0000028) | 3.63155856 |
33 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.62956731 |
34 | defense response to protozoan (GO:0042832) | 3.62508136 |
35 | positive regulation of type 2 immune response (GO:0002830) | 3.62119461 |
36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.56409051 |
37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.54008534 |
38 | leukocyte aggregation (GO:0070486) | 3.52982765 |
39 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.51967323 |
40 | mature B cell differentiation (GO:0002335) | 3.49279122 |
41 | response to interferon-beta (GO:0035456) | 3.48222338 |
42 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.43362704 |
43 | B cell proliferation (GO:0042100) | 3.42523868 |
44 | regulation of germinal center formation (GO:0002634) | 3.41883186 |
45 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.41699108 |
46 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.38642670 |
47 | positive regulation of interferon-alpha production (GO:0032727) | 3.34969613 |
48 | respiratory burst (GO:0045730) | 3.32574375 |
49 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.32132473 |
50 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.32132473 |
51 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.31233653 |
52 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.31233653 |
53 | response to protozoan (GO:0001562) | 3.30090197 |
54 | cellular response to type I interferon (GO:0071357) | 3.30021659 |
55 | type I interferon signaling pathway (GO:0060337) | 3.30021659 |
56 | response to type I interferon (GO:0034340) | 3.29703504 |
57 | cellular response to interferon-beta (GO:0035458) | 3.27217283 |
58 | myeloid dendritic cell activation (GO:0001773) | 3.23574546 |
59 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.20883439 |
60 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.20604128 |
61 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.20413198 |
62 | interferon-gamma production (GO:0032609) | 3.20086488 |
63 | regulation of interferon-alpha production (GO:0032647) | 3.19788687 |
64 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.19572223 |
65 | mature B cell differentiation involved in immune response (GO:0002313) | 3.19033447 |
66 | positive regulation of granulocyte differentiation (GO:0030854) | 3.17558386 |
67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.17200548 |
68 | regulation of B cell proliferation (GO:0030888) | 3.16592432 |
69 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.14145160 |
70 | positive regulation of T cell cytokine production (GO:0002726) | 3.12851699 |
71 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.10632321 |
72 | response to interferon-alpha (GO:0035455) | 3.10211591 |
73 | B cell mediated immunity (GO:0019724) | 3.09061270 |
74 | T cell costimulation (GO:0031295) | 3.08108975 |
75 | neutrophil activation (GO:0042119) | 3.07806408 |
76 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.07693170 |
77 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.07220295 |
78 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.06582989 |
79 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.06250646 |
80 | positive regulation of defense response to virus by host (GO:0002230) | 3.05480590 |
81 | negative regulation of phagocytosis (GO:0050765) | 3.04647360 |
82 | regulation of cell killing (GO:0031341) | 3.04568617 |
83 | lymphocyte costimulation (GO:0031294) | 3.03574295 |
84 | cytidine metabolic process (GO:0046087) | 3.03299322 |
85 | cytidine catabolic process (GO:0006216) | 3.03299322 |
86 | cytidine deamination (GO:0009972) | 3.03299322 |
87 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.03098467 |
88 | myeloid cell activation involved in immune response (GO:0002275) | 3.03059038 |
89 | positive regulation of cell killing (GO:0031343) | 3.02026592 |
90 | positive regulation of antigen processing and presentation (GO:0002579) | 3.02005136 |
91 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.00505643 |
92 | response to host immune response (GO:0052572) | 3.00505643 |
93 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.00398964 |
94 | regulation of gamma-delta T cell activation (GO:0046643) | 2.97794398 |
95 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.96558206 |
96 | cellular response to zinc ion (GO:0071294) | 2.96464481 |
97 | germinal center formation (GO:0002467) | 2.95634827 |
98 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.95395791 |
99 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.94770066 |
100 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94697422 |
101 | regulation of mast cell activation (GO:0033003) | 2.93491675 |
102 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.92500288 |
103 | mast cell activation involved in immune response (GO:0002279) | 2.92163197 |
104 | mast cell degranulation (GO:0043303) | 2.92163197 |
105 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91716448 |
106 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.91500805 |
107 | leukocyte degranulation (GO:0043299) | 2.90686765 |
108 | T cell homeostasis (GO:0043029) | 2.90680450 |
109 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.89446383 |
110 | granulocyte activation (GO:0036230) | 2.88971842 |
111 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.87127686 |
112 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86839593 |
113 | regulation of T-helper 1 type immune response (GO:0002825) | 2.86286383 |
114 | regulation of B cell activation (GO:0050864) | 2.85399938 |
115 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.84081301 |
116 | positive regulation of interferon-beta production (GO:0032728) | 2.83562335 |
117 | myeloid dendritic cell differentiation (GO:0043011) | 2.82922949 |
118 | DNA deamination (GO:0045006) | 2.82216160 |
119 | negative regulation of adaptive immune response (GO:0002820) | 2.81845183 |
120 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.81829628 |
121 | positive regulation of immunoglobulin production (GO:0002639) | 2.81208565 |
122 | neutrophil mediated immunity (GO:0002446) | 2.81060437 |
123 | negative regulation of viral genome replication (GO:0045071) | 2.81011206 |
124 | positive regulation of macrophage differentiation (GO:0045651) | 2.79198881 |
125 | superoxide anion generation (GO:0042554) | 2.77638276 |
126 | regulation of B cell apoptotic process (GO:0002902) | 2.77038331 |
127 | B cell homeostasis (GO:0001782) | 2.75893480 |
128 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.75619350 |
129 | response to muramyl dipeptide (GO:0032495) | 2.71211246 |
130 | lymphocyte homeostasis (GO:0002260) | 2.71077800 |
131 | T cell migration (GO:0072678) | 2.70741650 |
132 | lymph node development (GO:0048535) | 2.68701408 |
133 | definitive hemopoiesis (GO:0060216) | 2.66854459 |
134 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.66067678 |
135 | response to host (GO:0075136) | 2.66067678 |
136 | response to host defenses (GO:0052200) | 2.66067678 |
137 | regulation of antigen processing and presentation (GO:0002577) | 2.65193829 |
138 | macrophage activation involved in immune response (GO:0002281) | 2.64922908 |
139 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.64639483 |
140 | cellular response to exogenous dsRNA (GO:0071360) | 2.64012468 |
141 | megakaryocyte development (GO:0035855) | 2.61908797 |
142 | NIK/NF-kappaB signaling (GO:0038061) | 2.61010019 |
143 | platelet dense granule organization (GO:0060155) | 2.60755683 |
144 | lymphoid progenitor cell differentiation (GO:0002320) | 2.60609875 |
145 | myeloid leukocyte activation (GO:0002274) | 2.59578450 |
146 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.59440447 |
147 | regulation of mast cell degranulation (GO:0043304) | 2.58099329 |
148 | detection of other organism (GO:0098543) | 2.57870793 |
149 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.57827053 |
150 | positive regulation of B cell activation (GO:0050871) | 2.57740672 |
151 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.57667173 |
152 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.56188951 |
153 | positive regulation of B cell proliferation (GO:0030890) | 2.55798598 |
154 | negative T cell selection (GO:0043383) | 2.54257164 |
155 | T-helper 1 type immune response (GO:0042088) | 2.54249622 |
156 | B cell activation (GO:0042113) | 2.52998190 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.71798572 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.68008649 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.47665528 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.41309051 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.02009404 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.01758677 |
7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.72242215 |
8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.48286977 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.32423297 |
10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.27921918 |
11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.05768956 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.01164249 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.97580605 |
14 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.75814384 |
15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.75438554 |
16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.71491035 |
17 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.62133015 |
18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58804969 |
19 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.58653471 |
20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.53196275 |
21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.45162467 |
22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.44543819 |
23 | MYB_26560356_Chip-Seq_TH2_Human | 2.18866730 |
24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.12171375 |
25 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.08981978 |
26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.04693870 |
27 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02424787 |
28 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97870161 |
29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97702555 |
30 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.96439948 |
31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.94924012 |
32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.90882201 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89863655 |
34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.89748783 |
35 | MYB_26560356_Chip-Seq_TH1_Human | 1.86511750 |
36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85255078 |
37 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82440782 |
38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.81761179 |
39 | MAF_26560356_Chip-Seq_TH1_Human | 1.80243804 |
40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.76500759 |
41 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.75946996 |
42 | MYC_22102868_ChIP-Seq_BL_Human | 1.74450181 |
43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69029081 |
44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.68206991 |
45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.65702986 |
46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.60839230 |
47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59108968 |
48 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.57503431 |
49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.54579167 |
50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.51289462 |
51 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.51265213 |
52 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.48016295 |
53 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.42217870 |
54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41946137 |
55 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38296344 |
56 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.38192204 |
57 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.37009673 |
58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36392907 |
59 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.35720541 |
60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35280047 |
61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32018977 |
62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31898654 |
63 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.30772726 |
64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29650796 |
65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28402783 |
66 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.28399003 |
67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25822250 |
68 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.24369509 |
69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23458409 |
70 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.23076603 |
71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22658417 |
72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17237267 |
73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.17105251 |
74 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17077002 |
75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15923887 |
76 | MAF_26560356_Chip-Seq_TH2_Human | 1.13696948 |
77 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.12154600 |
78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10712471 |
79 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.09882277 |
80 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07910373 |
81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06902378 |
82 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.06306752 |
83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06238225 |
84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05125503 |
85 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04890310 |
86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04466722 |
87 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02097977 |
88 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01227213 |
89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01127591 |
90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00559564 |
91 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.00542096 |
92 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00060599 |
93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99731264 |
94 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.99361523 |
95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98466769 |
96 | P300_27268052_Chip-Seq_Bcells_Human | 0.98410352 |
97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97319046 |
98 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.96198500 |
99 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96092202 |
100 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.96025871 |
101 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.94872925 |
102 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92644422 |
103 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.91034041 |
104 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.90403612 |
105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89902097 |
106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89436219 |
107 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87496002 |
108 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85695985 |
109 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85432882 |
110 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85290739 |
111 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.84909141 |
112 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84597319 |
113 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.82133476 |
114 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.81881978 |
115 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.80160851 |
116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.79494231 |
117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79340009 |
118 | GATA3_26560356_Chip-Seq_TH1_Human | 0.78663742 |
119 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78314610 |
120 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78109842 |
121 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75408191 |
122 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.75328967 |
123 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74234852 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.57455814 |
2 | MP0009785_altered_susceptibility_to | 3.38119264 |
3 | MP0005671_abnormal_response_to | 3.25209854 |
4 | MP0001800_abnormal_humoral_immune | 3.05874403 |
5 | MP0002138_abnormal_hepatobiliary_system | 2.98023125 |
6 | MP0002148_abnormal_hypersensitivity_rea | 2.90819383 |
7 | MP0005000_abnormal_immune_tolerance | 2.90196653 |
8 | MP0003436_decreased_susceptibility_to | 2.85996435 |
9 | MP0000685_abnormal_immune_system | 2.83090109 |
10 | MP0002452_abnormal_antigen_presenting | 2.79976999 |
11 | MP0005387_immune_system_phenotype | 2.78681222 |
12 | MP0001790_abnormal_immune_system | 2.78681222 |
13 | MP0005025_abnormal_response_to | 2.78268849 |
14 | MP0002419_abnormal_innate_immunity | 2.65421377 |
15 | MP0003763_abnormal_thymus_physiology | 2.65048879 |
16 | MP0002723_abnormal_immune_serum | 2.64261247 |
17 | MP0002420_abnormal_adaptive_immunity | 2.57217305 |
18 | MP0001819_abnormal_immune_cell | 2.55014414 |
19 | MP0003724_increased_susceptibility_to | 2.43957006 |
20 | MP0005174_abnormal_tail_pigmentation | 2.43805468 |
21 | MP0002396_abnormal_hematopoietic_system | 2.39531626 |
22 | MP0002398_abnormal_bone_marrow | 2.28197807 |
23 | MP0005464_abnormal_platelet_physiology | 2.24009890 |
24 | MP0002166_altered_tumor_susceptibility | 2.20123734 |
25 | MP0000716_abnormal_immune_system | 2.08308585 |
26 | MP0001853_heart_inflammation | 1.99430866 |
27 | MP0002405_respiratory_system_inflammati | 1.99339797 |
28 | MP0000689_abnormal_spleen_morphology | 1.99053862 |
29 | MP0003303_peritoneal_inflammation | 1.97473323 |
30 | MP0002006_tumorigenesis | 1.96182738 |
31 | MP0002132_abnormal_respiratory_system | 1.95472506 |
32 | MP0002722_abnormal_immune_system | 1.79874871 |
33 | MP0002429_abnormal_blood_cell | 1.74995730 |
34 | MP0000015_abnormal_ear_pigmentation | 1.72737673 |
35 | MP0004808_abnormal_hematopoietic_stem | 1.72444647 |
36 | MP0009333_abnormal_splenocyte_physiolog | 1.69443474 |
37 | MP0010155_abnormal_intestine_physiology | 1.69329968 |
38 | MP0003300_gastrointestinal_ulcer | 1.68061044 |
39 | MP0000465_gastrointestinal_hemorrhage | 1.66989286 |
40 | MP0001845_abnormal_inflammatory_respons | 1.66549975 |
41 | MP0001545_abnormal_hematopoietic_system | 1.66308349 |
42 | MP0005397_hematopoietic_system_phenotyp | 1.66308349 |
43 | MP0005075_abnormal_melanosome_morpholog | 1.65956551 |
44 | MP0006082_CNS_inflammation | 1.62516974 |
45 | MP0002277_abnormal_respiratory_mucosa | 1.61460817 |
46 | MP0000372_irregular_coat_pigmentation | 1.50706423 |
47 | MP0001873_stomach_inflammation | 1.44894105 |
48 | MP0002933_joint_inflammation | 1.43708884 |
49 | MP0000490_abnormal_crypts_of | 1.42759751 |
50 | MP0002095_abnormal_skin_pigmentation | 1.40147803 |
51 | MP0003866_abnormal_defecation | 1.39845979 |
52 | MP0000703_abnormal_thymus_morphology | 1.38737371 |
53 | MP0008469_abnormal_protein_level | 1.36090808 |
54 | MP0000371_diluted_coat_color | 1.34551038 |
55 | MP0009697_abnormal_copulation | 1.31237986 |
56 | MP0001986_abnormal_taste_sensitivity | 1.28684531 |
57 | MP0009764_decreased_sensitivity_to | 1.28638961 |
58 | MP0004510_myositis | 1.25782231 |
59 | MP0002163_abnormal_gland_morphology | 1.23016234 |
60 | MP0004947_skin_inflammation | 1.21440052 |
61 | MP0009278_abnormal_bone_marrow | 1.19477615 |
62 | MP0001533_abnormal_skeleton_physiology | 1.19061678 |
63 | MP0005310_abnormal_salivary_gland | 1.19011741 |
64 | MP0008057_abnormal_DNA_replication | 1.18884492 |
65 | MP0008058_abnormal_DNA_repair | 1.12188626 |
66 | MP0003183_abnormal_peptide_metabolism | 1.11073184 |
67 | MP0000569_abnormal_digit_pigmentation | 1.10323448 |
68 | MP0000858_altered_metastatic_potential | 1.08933688 |
69 | MP0005409_darkened_coat_color | 1.08724615 |
70 | MP0010094_abnormal_chromosome_stability | 1.07872017 |
71 | MP0006292_abnormal_olfactory_placode | 1.04054878 |
72 | MP0003693_abnormal_embryo_hatching | 1.03511862 |
73 | MP0002009_preneoplasia | 1.03237758 |
74 | MP0003448_altered_tumor_morphology | 1.02959078 |
75 | MP0008007_abnormal_cellular_replicative | 1.01484360 |
76 | MP0004381_abnormal_hair_follicle | 0.98791368 |
77 | MP0002075_abnormal_coat/hair_pigmentati | 0.97839007 |
78 | MP0000343_altered_response_to | 0.96225243 |
79 | MP0003172_abnormal_lysosome_physiology | 0.87501864 |
80 | MP0002019_abnormal_tumor_incidence | 0.86676174 |
81 | MP0001663_abnormal_digestive_system | 0.85614491 |
82 | MP0005379_endocrine/exocrine_gland_phen | 0.85032955 |
83 | MP0001186_pigmentation_phenotype | 0.83671174 |
84 | MP0003806_abnormal_nucleotide_metabolis | 0.83501184 |
85 | MP0005058_abnormal_lysosome_morphology | 0.82155939 |
86 | MP0005171_absent_coat_pigmentation | 0.81540733 |
87 | MP0003828_pulmonary_edema | 0.81155114 |
88 | MP0008260_abnormal_autophagy | 0.78887454 |
89 | MP0000681_abnormal_thyroid_gland | 0.77013921 |
90 | MP0001188_hyperpigmentation | 0.76144027 |
91 | MP0003077_abnormal_cell_cycle | 0.75381292 |
92 | MP0003191_abnormal_cellular_cholesterol | 0.74209379 |
93 | MP0009763_increased_sensitivity_to | 0.74131456 |
94 | MP0003045_fibrosis | 0.73344181 |
95 | MP0002136_abnormal_kidney_physiology | 0.70493155 |
96 | MP0003252_abnormal_bile_duct | 0.70437963 |
97 | MP0004782_abnormal_surfactant_physiolog | 0.70042257 |
98 | MP0003656_abnormal_erythrocyte_physiolo | 0.68323631 |
99 | MP0002928_abnormal_bile_duct | 0.67047487 |
100 | MP0003186_abnormal_redox_activity | 0.66072752 |
101 | MP0008877_abnormal_DNA_methylation | 0.65392956 |
102 | MP0002998_abnormal_bone_remodeling | 0.64809185 |
103 | MP0005645_abnormal_hypothalamus_physiol | 0.64776050 |
104 | MP0006036_abnormal_mitochondrial_physio | 0.64718128 |
105 | MP0002693_abnormal_pancreas_physiology | 0.63584410 |
106 | MP0003136_yellow_coat_color | 0.62148462 |
107 | MP0000313_abnormal_cell_death | 0.57536783 |
108 | MP0009765_abnormal_xenobiotic_induced | 0.57386085 |
109 | MP0001851_eye_inflammation | 0.57309468 |
110 | MP0005390_skeleton_phenotype | 0.57214907 |
111 | MP0005408_hypopigmentation | 0.56470836 |
112 | MP0005166_decreased_susceptibility_to | 0.56454269 |
113 | MP0000609_abnormal_liver_physiology | 0.54674804 |
114 | MP0000249_abnormal_blood_vessel | 0.54626566 |
115 | MP0010307_abnormal_tumor_latency | 0.53919436 |
116 | MP0001881_abnormal_mammary_gland | 0.53098074 |
117 | MP0002083_premature_death | 0.47907932 |
118 | MP0002876_abnormal_thyroid_physiology | 0.45734608 |
119 | MP0008874_decreased_physiological_sensi | 0.45274346 |
120 | MP0001764_abnormal_homeostasis | 0.44534379 |
121 | MP0009643_abnormal_urine_homeostasis | 0.42770941 |
122 | MP0003786_premature_aging | 0.42745501 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.33626780 |
2 | Recurrent bacterial skin infections (HP:0005406) | 4.71922274 |
3 | Eczematoid dermatitis (HP:0000976) | 4.39833301 |
4 | Myositis (HP:0100614) | 4.15663239 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.13607695 |
6 | Recurrent fungal infections (HP:0002841) | 3.64315691 |
7 | IgM deficiency (HP:0002850) | 3.63072254 |
8 | Mediastinal lymphadenopathy (HP:0100721) | 3.60414701 |
9 | Thrombocytosis (HP:0001894) | 3.60331896 |
10 | Verrucae (HP:0200043) | 3.57683680 |
11 | Papilloma (HP:0012740) | 3.57683680 |
12 | Recurrent viral infections (HP:0004429) | 3.52029686 |
13 | Meningitis (HP:0001287) | 3.50968833 |
14 | Panhypogammaglobulinemia (HP:0003139) | 3.46819238 |
15 | Agammaglobulinemia (HP:0004432) | 3.43238683 |
16 | Recurrent skin infections (HP:0001581) | 3.40436510 |
17 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.33705953 |
18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.33705953 |
19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.30185614 |
20 | Obstructive lung disease (HP:0006536) | 3.30185614 |
21 | Optic neuritis (HP:0100653) | 3.28610140 |
22 | Retrobulbar optic neuritis (HP:0100654) | 3.28610140 |
23 | Vasculitis (HP:0002633) | 3.28319244 |
24 | Spontaneous hematomas (HP:0007420) | 3.22790876 |
25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.20343728 |
26 | Orchitis (HP:0100796) | 3.20094644 |
27 | Stomatitis (HP:0010280) | 3.15570273 |
28 | Chronic otitis media (HP:0000389) | 3.12736348 |
29 | Gastrointestinal infarctions (HP:0005244) | 3.10623411 |
30 | Abnormality of macrophages (HP:0004311) | 3.10183627 |
31 | Recurrent pneumonia (HP:0006532) | 3.03893607 |
32 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.03786599 |
33 | Recurrent bronchitis (HP:0002837) | 3.01740118 |
34 | IgG deficiency (HP:0004315) | 2.98283235 |
35 | Autoimmune hemolytic anemia (HP:0001890) | 2.96733798 |
36 | Petechiae (HP:0000967) | 2.91353711 |
37 | Cellulitis (HP:0100658) | 2.89147527 |
38 | Abnormality of the prostate (HP:0008775) | 2.88054495 |
39 | Reduced antithrombin III activity (HP:0001976) | 2.85448065 |
40 | Abnormality of B cell number (HP:0010975) | 2.83768511 |
41 | B lymphocytopenia (HP:0010976) | 2.83768511 |
42 | Recurrent lower respiratory tract infections (HP:0002783) | 2.75240121 |
43 | Thyroiditis (HP:0100646) | 2.74797015 |
44 | Prolonged bleeding time (HP:0003010) | 2.74699845 |
45 | Osteomyelitis (HP:0002754) | 2.72004753 |
46 | Vacuolated lymphocytes (HP:0001922) | 2.70704927 |
47 | Gastrointestinal stroma tumor (HP:0100723) | 2.70406064 |
48 | Hypothermia (HP:0002045) | 2.68617149 |
49 | Chronic sinusitis (HP:0011109) | 2.67676922 |
50 | Abnormality of T cell physiology (HP:0011840) | 2.66016705 |
51 | Inflammation of the large intestine (HP:0002037) | 2.65107251 |
52 | Pustule (HP:0200039) | 2.65051602 |
53 | Chronic diarrhea (HP:0002028) | 2.64367940 |
54 | Anhidrosis (HP:0000970) | 2.62263802 |
55 | Lymphopenia (HP:0001888) | 2.61447104 |
56 | Abnormality of the pleura (HP:0002103) | 2.61243440 |
57 | Abnormality of T cells (HP:0002843) | 2.59323723 |
58 | Pulmonary infiltrates (HP:0002113) | 2.54720878 |
59 | Bronchitis (HP:0012387) | 2.52800275 |
60 | Abnormal number of erythroid precursors (HP:0012131) | 2.51601782 |
61 | Hypokalemic alkalosis (HP:0001949) | 2.51566698 |
62 | Recurrent sinusitis (HP:0011108) | 2.49477394 |
63 | Encephalitis (HP:0002383) | 2.49404724 |
64 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.48956091 |
65 | Leukocytosis (HP:0001974) | 2.48745745 |
66 | Restrictive lung disease (HP:0002091) | 2.48652021 |
67 | Skin rash (HP:0000988) | 2.48248985 |
68 | Eosinophilia (HP:0001880) | 2.47914334 |
69 | Gastrointestinal inflammation (HP:0004386) | 2.44833862 |
70 | Chest pain (HP:0100749) | 2.44773861 |
71 | Type I transferrin isoform profile (HP:0003642) | 2.43806585 |
72 | Prostate neoplasm (HP:0100787) | 2.43499374 |
73 | Combined immunodeficiency (HP:0005387) | 2.41649863 |
74 | Reticulocytopenia (HP:0001896) | 2.41223621 |
75 | Granulocytopenia (HP:0001913) | 2.39773396 |
76 | Gingivitis (HP:0000230) | 2.38156931 |
77 | Decreased circulating renin level (HP:0003351) | 2.37650179 |
78 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.36854181 |
79 | Epistaxis (HP:0000421) | 2.36492992 |
80 | Hyperactive renin-angiotensin system (HP:0000841) | 2.35932598 |
81 | Colitis (HP:0002583) | 2.35519421 |
82 | Neutropenia (HP:0001875) | 2.33705528 |
83 | Aplastic anemia (HP:0001915) | 2.31047618 |
84 | Pulmonary embolism (HP:0002204) | 2.30969431 |
85 | Urticaria (HP:0001025) | 2.29879624 |
86 | Joint swelling (HP:0001386) | 2.29419955 |
87 | Stomach cancer (HP:0012126) | 2.29138611 |
88 | IgA deficiency (HP:0002720) | 2.28041801 |
89 | Abnormality of eosinophils (HP:0001879) | 2.27153741 |
90 | Arterial thrombosis (HP:0004420) | 2.27039245 |
91 | Periodontitis (HP:0000704) | 2.26780847 |
92 | Lymphoma (HP:0002665) | 2.26488498 |
93 | T lymphocytopenia (HP:0005403) | 2.26483891 |
94 | Gingival bleeding (HP:0000225) | 2.25493212 |
95 | Abnormality of T cell number (HP:0011839) | 2.24830976 |
96 | Keratoconjunctivitis (HP:0001096) | 2.23081758 |
97 | Emphysema (HP:0002097) | 2.22706865 |
98 | Viral hepatitis (HP:0006562) | 2.21482936 |
99 | Chromsome breakage (HP:0040012) | 2.18630948 |
100 | Basal ganglia calcification (HP:0002135) | 2.18224945 |
101 | Abnormality of male internal genitalia (HP:0000022) | 2.17732919 |
102 | Hyperaldosteronism (HP:0000859) | 2.16982754 |
103 | Alveolar cell carcinoma (HP:0006519) | 2.15762273 |
104 | Hemoptysis (HP:0002105) | 2.15495572 |
105 | Severe combined immunodeficiency (HP:0004430) | 2.14956081 |
106 | Microcytic anemia (HP:0001935) | 2.14336571 |
107 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.12880537 |
108 | Autoimmune thrombocytopenia (HP:0001973) | 2.12357370 |
109 | Gangrene (HP:0100758) | 2.11906534 |
110 | Abnormality of chloride homeostasis (HP:0011422) | 2.10321398 |
111 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.08256448 |
112 | Keratoconjunctivitis sicca (HP:0001097) | 2.07756114 |
113 | Leukopenia (HP:0001882) | 2.07567049 |
114 | Pulmonary fibrosis (HP:0002206) | 2.06862417 |
115 | Skin ulcer (HP:0200042) | 2.06017711 |
116 | Abnormality of the right ventricle (HP:0001707) | 2.04748124 |
117 | Hyponatremia (HP:0002902) | 2.02701381 |
118 | Sepsis (HP:0100806) | 2.00426971 |
119 | Clubbing of toes (HP:0100760) | 1.96653994 |
120 | Hypoplasia of the thymus (HP:0000778) | 1.94976587 |
121 | Abnormal platelet function (HP:0011869) | 1.94140413 |
122 | Impaired platelet aggregation (HP:0003540) | 1.94140413 |
123 | Increased IgE level (HP:0003212) | 1.94117322 |
124 | Exertional dyspnea (HP:0002875) | 1.93879096 |
125 | Increased IgM level (HP:0003496) | 1.93758016 |
126 | Albinism (HP:0001022) | 1.92295608 |
127 | Acute hepatic failure (HP:0006554) | 1.91483689 |
128 | Amaurosis fugax (HP:0100576) | 1.90694323 |
129 | Arthralgia (HP:0002829) | 1.90391793 |
130 | Hypergammaglobulinemia (HP:0010702) | 1.89568483 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.68063440 |
2 | IRAK4 | 3.26027688 |
3 | TXK | 3.07837803 |
4 | KIT | 2.89744642 |
5 | TEC | 2.64768859 |
6 | IRAK3 | 2.59692272 |
7 | MAP3K14 | 2.48518140 |
8 | LMTK2 | 2.39751676 |
9 | BLK | 2.34384514 |
10 | BTK | 2.30424988 |
11 | IKBKE | 2.09837601 |
12 | NME2 | 1.95333759 |
13 | TBK1 | 1.94158009 |
14 | TYK2 | 1.89444643 |
15 | RIPK4 | 1.89028080 |
16 | SYK | 1.88489596 |
17 | CSF1R | 1.86867216 |
18 | TNIK | 1.81814050 |
19 | IKBKB | 1.78794842 |
20 | ZAP70 | 1.74673452 |
21 | TAOK1 | 1.74354540 |
22 | JAK3 | 1.72214420 |
23 | EIF2AK3 | 1.57078459 |
24 | TESK2 | 1.54833483 |
25 | MAPKAPK3 | 1.53450485 |
26 | MAP3K10 | 1.52924636 |
27 | STK16 | 1.50842268 |
28 | FES | 1.48246455 |
29 | TGFBR2 | 1.44672824 |
30 | ACVR1B | 1.41016571 |
31 | NLK | 1.40727836 |
32 | LYN | 1.40015006 |
33 | TAOK3 | 1.34066240 |
34 | TLK1 | 1.33900867 |
35 | EIF2AK2 | 1.30116932 |
36 | LCK | 1.27426420 |
37 | PRKG2 | 1.27338519 |
38 | CLK1 | 1.25404685 |
39 | HCK | 1.24925661 |
40 | PIM2 | 1.23499993 |
41 | SIK3 | 1.23124220 |
42 | MKNK2 | 1.22654636 |
43 | FLT3 | 1.17472413 |
44 | SRPK1 | 1.11802746 |
45 | ITK | 1.10556646 |
46 | PIM1 | 1.10392181 |
47 | JAK1 | 1.09550907 |
48 | STK10 | 1.08821247 |
49 | MKNK1 | 1.04596983 |
50 | MAP2K3 | 1.03852351 |
51 | CSK | 1.00570882 |
52 | MATK | 0.98375987 |
53 | MAPK11 | 0.95915257 |
54 | TGFBR1 | 0.93969978 |
55 | PRPF4B | 0.93063201 |
56 | CHUK | 0.92221909 |
57 | MAP2K2 | 0.92127782 |
58 | SIK2 | 0.91410264 |
59 | GRK6 | 0.89836022 |
60 | IRAK1 | 0.89035381 |
61 | ADRBK2 | 0.88604352 |
62 | YES1 | 0.86757343 |
63 | MST4 | 0.80469715 |
64 | FRK | 0.80216448 |
65 | MUSK | 0.79193083 |
66 | CCNB1 | 0.78992373 |
67 | MAP3K12 | 0.78941244 |
68 | ZAK | 0.78079767 |
69 | TAOK2 | 0.75212753 |
70 | RPS6KA4 | 0.74124192 |
71 | PASK | 0.73980954 |
72 | TNK2 | 0.72176347 |
73 | VRK1 | 0.72146199 |
74 | STK4 | 0.72030277 |
75 | TRPM7 | 0.71560656 |
76 | BMPR1B | 0.70662079 |
77 | HIPK2 | 0.68936822 |
78 | BMPR2 | 0.66636292 |
79 | VRK2 | 0.65492437 |
80 | MARK3 | 0.64043095 |
81 | BRD4 | 0.63565117 |
82 | GRK7 | 0.63257233 |
83 | KDR | 0.61671223 |
84 | NEK9 | 0.59549355 |
85 | MAP3K13 | 0.58781473 |
86 | EIF2AK1 | 0.58354645 |
87 | IRAK2 | 0.57477511 |
88 | PDK1 | 0.55899585 |
89 | ATR | 0.55354276 |
90 | FGFR3 | 0.54525343 |
91 | MAP3K11 | 0.50333882 |
92 | MAP3K1 | 0.49491606 |
93 | ERN1 | 0.49466402 |
94 | WEE1 | 0.48439839 |
95 | NUAK1 | 0.48193987 |
96 | DYRK3 | 0.48166025 |
97 | GRK1 | 0.47342589 |
98 | MAP3K3 | 0.46953305 |
99 | PRKCD | 0.46757044 |
100 | MAP2K6 | 0.46560379 |
101 | FYN | 0.44566562 |
102 | PRKCQ | 0.44485162 |
103 | MAPKAPK2 | 0.43996225 |
104 | MAP3K5 | 0.43341045 |
105 | LRRK2 | 0.42407291 |
106 | DAPK1 | 0.42098282 |
107 | CDK19 | 0.42057815 |
108 | MAPK4 | 0.41968370 |
109 | ABL1 | 0.40060517 |
110 | CDK4 | 0.37548336 |
111 | IGF1R | 0.36740180 |
112 | MAPK12 | 0.35907643 |
113 | RPS6KA5 | 0.34952214 |
114 | NEK2 | 0.34413270 |
115 | SCYL2 | 0.34122985 |
116 | MAPK3 | 0.32372461 |
117 | CAMKK2 | 0.32282528 |
118 | INSR | 0.32265506 |
119 | JAK2 | 0.32147686 |
120 | PIK3CG | 0.30646181 |
121 | TIE1 | 0.30277926 |
122 | FGR | 0.30058845 |
123 | MAP4K2 | 0.29090831 |
124 | SMG1 | 0.28674104 |
125 | PRKD2 | 0.27186339 |
126 | MAPK7 | 0.24403056 |
127 | CAMKK1 | 0.24069461 |
128 | ALK | 0.23702653 |
129 | MAP3K8 | 0.21986328 |
130 | CDK6 | 0.18019743 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.41527458 |
2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.74746129 |
3 | DNA replication_Homo sapiens_hsa03030 | 2.69312188 |
4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.67604803 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54186561 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.44367501 |
7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.27762853 |
8 | Measles_Homo sapiens_hsa05162 | 2.23050378 |
9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21227731 |
10 | Ribosome_Homo sapiens_hsa03010 | 2.20014552 |
11 | Allograft rejection_Homo sapiens_hsa05330 | 2.13609214 |
12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.13230030 |
13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.06145822 |
14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.02047610 |
15 | Mismatch repair_Homo sapiens_hsa03430 | 1.88183285 |
16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.86380171 |
17 | Base excision repair_Homo sapiens_hsa03410 | 1.86237723 |
18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.85371817 |
19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81408068 |
20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.74158847 |
21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.72049708 |
22 | Homologous recombination_Homo sapiens_hsa03440 | 1.70065986 |
23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65496009 |
24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60287334 |
25 | Asthma_Homo sapiens_hsa05310 | 1.56725230 |
26 | Legionellosis_Homo sapiens_hsa05134 | 1.52670990 |
27 | Influenza A_Homo sapiens_hsa05164 | 1.46429352 |
28 | Pertussis_Homo sapiens_hsa05133 | 1.45320875 |
29 | Malaria_Homo sapiens_hsa05144 | 1.43647108 |
30 | Tuberculosis_Homo sapiens_hsa05152 | 1.43071816 |
31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39846278 |
32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38083459 |
33 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.33742106 |
34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27337884 |
35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.27214462 |
36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25136615 |
37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22085742 |
38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.21904842 |
39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.20360371 |
40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.19678180 |
41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.17107014 |
42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.14359296 |
43 | RNA polymerase_Homo sapiens_hsa03020 | 1.07281483 |
44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05751541 |
45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05087245 |
46 | Spliceosome_Homo sapiens_hsa03040 | 1.04601553 |
47 | Apoptosis_Homo sapiens_hsa04210 | 1.04520866 |
48 | Hepatitis B_Homo sapiens_hsa05161 | 1.03545020 |
49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03376429 |
50 | Shigellosis_Homo sapiens_hsa05131 | 1.02747525 |
51 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01048187 |
52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96680293 |
53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95408870 |
54 | Salmonella infection_Homo sapiens_hsa05132 | 0.95309821 |
55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95027005 |
56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92797637 |
57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89239838 |
58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.88991466 |
59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85888737 |
60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84669284 |
61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84273578 |
62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82793575 |
63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81591239 |
64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78458853 |
65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76197998 |
66 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.74196158 |
67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.73640569 |
68 | Hepatitis C_Homo sapiens_hsa05160 | 0.73601163 |
69 | Phagosome_Homo sapiens_hsa04145 | 0.73266011 |
70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72970382 |
71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71699833 |
72 | RNA degradation_Homo sapiens_hsa03018 | 0.71554392 |
73 | Lysosome_Homo sapiens_hsa04142 | 0.65126077 |
74 | Platelet activation_Homo sapiens_hsa04611 | 0.64096527 |
75 | Protein export_Homo sapiens_hsa03060 | 0.63712687 |
76 | Proteasome_Homo sapiens_hsa03050 | 0.62850271 |
77 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62331608 |
78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60610056 |
79 | Basal transcription factors_Homo sapiens_hsa03022 | 0.59079827 |
80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56995315 |
81 | Purine metabolism_Homo sapiens_hsa00230 | 0.56888315 |
82 | Cell cycle_Homo sapiens_hsa04110 | 0.56468716 |
83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54160581 |
84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53552939 |
85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53351302 |
86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46408055 |
87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44342420 |
88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41208104 |
89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38987859 |
90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38382962 |
91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38053766 |
92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37169789 |
93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36778319 |
94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36463155 |
95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33790840 |
96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32576059 |
97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.32554174 |
98 | ABC transporters_Homo sapiens_hsa02010 | 0.30705833 |
99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30392517 |
100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30376871 |
101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30079813 |
102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29366713 |
103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29081624 |
104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28588376 |
105 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.27130479 |
106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26408686 |
107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24756546 |
108 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.22527633 |
109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.20462503 |
110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.20133771 |
111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20118365 |
112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18893603 |
113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.16924326 |
114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14702592 |
115 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.12109236 |
116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.11512124 |
117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10814434 |
118 | Peroxisome_Homo sapiens_hsa04146 | 0.09967410 |
119 | Alcoholism_Homo sapiens_hsa05034 | 0.09763456 |
120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08905456 |
121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.07034078 |
122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.06588224 |
123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.06004096 |